Prostanex
Prostanex, licence 80076727: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Graminex LLC
- NPN or DIN-HM
- 80076727
- Status
- Active licence
- Licence date
- 13 April 2017
- Revision date
- 13 June 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Extrait de pollen Source : Secale cereale - Anthère Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1022.4 milligramme | 51.12 milligramme | Not calculated |
| Secale cereale Source : Pollen Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 51.2 milligramme Potency : 7.0 % Phytosterols | 2.56 milligramme | Not calculated |
| Serenoa repens Source : Fruit Extract : Matériel brut sec Extraction ratio : 1:1.001 Dry plant equivalent : 112.64 milligramme | 112.76 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Phosphate de tricalcium, Dioxyde de silicium, Phosphate de calcium, monobasique, Stéarate de calcium, Cellulose microcristalline, Gomme arabique, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
May help to support healthy prostate function and quality of life. May help relieve in frequent day time and night time urination, associated with benign prostatic hyperplasia (BHP). May help to support healthy prostate function and urinary flow rate. May help to support with dysuria, day time and night time urinary frequency, and urinary flow rate. May help to support improved night time urinary frequency (nocturia). Saw Palmetto is used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. May help to support prostate health. May help to support quality of life. May help to support sexual health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80076727
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.